Yin Y, Xu H, He L, Brown JR, Mato AR, Aittokallio T, Skånland SS (2025)
Protein profiles predict treatment responses to the PI3K inhibitor umbralisib in patients with chronic lymphocytic leukemia
Clin Cancer Res (in press)
DOI 10.1158/1078-0432.CCR-24-2911, PubMed 40085050

Huusari R, Wang T, Szedmak S, Dias D, Aittokallio T, Rousu J (2025)
Scaling up drug combination surface prediction
Brief Bioinform, 26 (2)
DOI 10.1093/bib/bbaf099, PubMed 40079263

Nygren PJ, Bouhlal JOV, Jokinen E, Forstén S, Laajala E, Dias DAA, Adnan Awad S, Ianevski A, Klievink J, Lähteenmäki H, Kuusanmäki H, Myllymäki M, Kasanen T, Saeed K, Lee DA, Flagship I, Hjorth-Hansen H, Aittokallio T, Dufva O, Mustjoki S (2025)
High-throughput drug screening identifies SMAC mimetics as enhancers of NK cell cytotoxicity in chronic myeloid leukemia
Blood (in press)
DOI 10.1182/blood.2024025286, PubMed 39792962